Terms: = Colorectal cancer AND TRB AND Treatment
6 results:
1. Anti-VEGF and Anti-EGFR Antibody Therapy on T-Cell Infiltration and TCR Variation in Metastatic colorectal cancer.
Xu M; Tsunedomi R; Kiyotani K; Tomochika S; Furuya K; Nakajima M; Matsui H; Tokumitsu Y; Shindo Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
Anticancer Res; 2023 Feb; 43(2):613-620. PubMed ID: 36697107
[TBL] [Abstract] [Full Text] [Related]
2. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.
Shrimali D; Shanmugam MK; Kumar AP; Zhang J; Tan BK; Ahn KS; Sethi G
Cancer Lett; 2013 Dec; 341(2):139-49. PubMed ID: 23962559
[TBL] [Abstract] [Full Text] [Related]
3. CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis.
Serafino A; Zonfrillo M; Andreola F; Psaila R; Mercuri L; Moroni N; Renier D; Campisi M; Secchieri C; Pierimarchi P
Curr Cancer Drug Targets; 2011 Jun; 11(5):572-85. PubMed ID: 21486216
[TBL] [Abstract] [Full Text] [Related]
4. Reduction of peritoneal carcinomatosis by intraperitoneal administration of phospholipids in rats.
Otto J; Jansen PL; Lucas S; Schumpelick V; Jansen M
BMC Cancer; 2007 Jun; 7():104. PubMed ID: 17584925
[TBL] [Abstract] [Full Text] [Related]
5. In vitro thermochemotherapy of colon cancer cell lines with irinotecan alone and combined with mitomycin C.
Le Page S; Kwiatkowski F; Paulin C; Mohamed F; Pezet D; Chipponi J; Benhamed M; Gilly FN; Glehen O
Hepatogastroenterology; 2006; 53(71):693-7. PubMed ID: 17086870
[TBL] [Abstract] [Full Text] [Related]
6. Expression of human tumor mucin-associated carbohydrate epitopes, including sialylated Tn, and localization of murine monoclonal antibodies CC49 and B72.3 in a syngeneic rat colon carcinoma model.
O'Boyle KP; Goya V; Zuckier LS; Chun S; Bhargava K
J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):251-61. PubMed ID: 7533599
[TBL] [Abstract] [Full Text] [Related]
